We are live on ! Find out more
CELU icon

Celularity
CELU

Fund managers haven’t disclosed any holdings of CELU yet.

CELU Hedge Fund Activity: Q1 2026 in Review

38 of the 8,125 institutional investors tracked by Wall St. Rank reported a position in Celularity (CELU) for Q1 2026, worth a combined $2.88M — down 9.6% from $3.19M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new CELU positions and 6 closed out — a net gain of 4 holders — while 4 added to existing stakes and 5 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $39.1K. The largest seller was Citadel Advisors, exiting entirely with an estimated $86.2K sold.

  • 38 institutional investors held Celularity (CELU) as of Q1 2026, up from 36 in Q4 2025.
  • Funds reported $2.88M of Celularity stock for Q1 2026, down 9.6% quarter-over-quarter.
  • 10 funds opened new Celularity positions in Q1 2026 and 6 closed out, a net change of +4 holders.
  • The largest Celularity buyer in Q1 2026 was Geode Capital Management, an estimated $39.1K added.
  • The largest Celularity seller in Q1 2026 was Citadel Advisors, an estimated $86.2K sold.

Based on aggregated 13F filings for Q1 2026.